Nelson Advisors: M&A, Innovation and AI - 10 Key Points from the 2026 Morgan Stanley Global Healthcare Conference
2026 Morgan Stanley Global Healthcare Conference
'As healthcare leaders and investors gathered at the 2026 Morgan Stanley Global Healthcare Conference, conversations centered on an industry balancing innovation, growth and disruption. Morgan Stanley bankers highlighted a stronger financing environment in biotech, robust demand for differentiated therapies and technologies and the growing importance of data and AI across healthcare. Executives also discussed advances in oncology and obesity, the outlook for healthcare M&A and the growing role of Chinese biotech in the global innovation ecosystem.'
The 2026 Morgan Stanley Global Healthcare Conference highlighted how biopharma and healthcare executives are balancing patent cliffs, strategic acquisitions and rapid AI integration to sustain long term growth.
Preparing for the Late-Decade Patent Cliff: Large pharma companies are facing major loss-of-exclusivity events heading toward the end of the decade, making pipeline renewal and external innovation indispensable to replace anticipated revenue shortfalls.
Aggressive Expansion into High-Growth Modalities: To offset patent vulnerabilities, capital is pouring heavily into oncology, immunology and inflammation (I&I), cell therapy, rare diseases, and next-generation diagnostics.
Beyond First-Generation Therapies (Obesity & Oncology): In cardiometabolic health and oncology, companies are differentiating away from commoditised treatments by developing oral formulations, longer-duration injectables, and next-wave immunotherapies such as T-cell priming across broader solid tumour types (e.g., lung, bladder, renal).
Healthcare M&A Dynamics
Biopharma Dominates Deal Volume: Strategic acquirers—rather than financial sponsors—are driving market momentum, with biopharma transactions accounting for roughly 70% of total healthcare deal activity.
Robust Strategic Appetite Across Regions: The biopharma M&A environment is seeing its strongest momentum in years, supported by breakout clinical trial readouts and active bidding from large and small buyers across North America and Europe looking to buy growth.
Biotech as the Core Engine of Scale: Because internal R&D productivity alone cannot replace looming patent expirations, pharma leaders reinforced that acquired biotech platforms remain the primary solution for sustained pipeline replenishment.
AI & Data Assets Entering Deal Diligence: Acquirers are recalibrating valuation frameworks to assess targets not just on clinical pipelines, but also on proprietary data sets, technological moats, and operational models that can benefit from automated productivity gains.
AI Adoption & Data Commercialisation
Unlocking Value from Longitudinal Clinical Data: While healthcare historically excelled at capturing genomics, imaging, and longitudinal patient records, advances in AI tooling are now enabling organisations to convert these dormant proprietary data sets into tangible discovery and diagnostic assets.
Accelerating Discovery & Operational Timelines: AI is compressing R&D cycles by predicting molecular behaviour, screening compounds faster, lowering trial costs, and augmenting specialised commercial and scientific teams.
Provider Workflows and Post-Discharge Engagement: On the clinical delivery side, health systems are deploying AI agents for post-discharge patient monitoring, such as tracking symptoms, confirming follow-ups, and managing medication refills, reducing administrative burnout while lowering hospital readmission rates.
Nelson Advisors > European Healthcare Technology Investment Banking
Nelson Advisors specialise in Mergers and Acquisitions for European HealthTech, MedTech, Digital Health, Healthcare IT, Healthcare AI companies in the Lower to Mid Market ranging from $25M to $250M EV. www.nelsonadvisors.co.uk
Healthcare.Digital is the Google News approved HealthTech and MedTech Thought Leadership platform for Nelson Advisors, positioning them as a specialised authority on European Healthcare Technology M&A and strategic corporate development. https://www.healthcare.digital
Nelson Advisors publish Europe's Leading Healthcare Technology Investment Banking Newsletter every week, join 5000+ HealthTech and MedTech subscribers today! https://lnkd.in/e5hTp_xb
Healthcare.Digital serves as a research platform for Nelson Advisors’ perspectives on deals, valuations and structural shifts reshaping Global Digital Health, MedTech, Healthcare AI and Health IT. https://www.healthcare.digital
Nelson Advisors is one of Europe's leading mergers and acquisitions advisory firms, exclusively dedicated to the dynamic and rapidly evolving healthcare technology sector. With a deep understanding of market dynamics and technological advancements, they empower innovative HealthTech companies and strategic investors to navigate complex transactions and achieve their growth ambitions. www.nelsonadvisors.co.uk
#NelsonAdvisors #HealthTech#MedTech#DigitalHealth #HealthIT #Cybersecurity #HealthcareAI #FemTech#ConsumerHealth #Mergers #Acquisitions #Partnerships #Growth #Strategy #NHS #UK #Europe #USA #Canada#Commonwealth#CorporateDivestitures #VentureCapital #PrivateEquity #Founders #SeriesA #SeriesB #Founders #SellSide #TechAssets #Fundraising #BuildBuyPartner #GoToMarket #PharmaTech #Genomics
Nelson Advisors
Hale House, 76-78 Portland Place, Marylebone, London, W1B 1NT
Meet Nelson Advisors @ Events in 2026
Digital Health Rewired > March 2026 > Birmingham, UK
NHS ConfedExpo > June 2026 > Manchester, UK
HLTH Europe > June 2026, Amsterdam, Netherlands
HIMSS AI in Healthcare > July 2026, New York, USA
Bits & Pretzels > September 2026, Munich, Germany
HealthInvestor Healthcare Summit > September 2026, London, UK
World Health Summit 2026 > October 2026, Berlin, Germany
HLTH USA 2026 > October 2026, USA
Global Health Exhibition 2026 > October 2026, Riyadh, Saudi Arabia
Web Summit 2026 > November 2026, Lisbon, Portugal
MEDICA 2026 > November 2026, Düsseldorf, Germany
Leaders in Health Summit 2026 > November 2026, London, UK
Venture Capital World Summit > December 2026, Toronto, Canada
Meet Nelson Advisors @ Events in 2027
Digital Health Rewired > March 2027 > Birmingham, UK
Barclays Health Elevate > March 2027, London, UK
NHS ConfedExpo > June 2027 > Manchester, UK
HLTH Europe > June 2027, Amsterdam, Netherlands
Comments